Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897

Inge Tetens

Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897

Inge Tetens

National Food Institute

Research output: Book/Report › Report › Research › peer-review

Original language	English

Publisher	European Food Safety Authority
Publication status	Published - 2010

Keywords

anti-inflammatory cytokines
insulin sensitivity
t11 and t10
pro-inflammatory
immune defences
Conjugated linoleic acid (CLA)
isomers c9
health claims
body weight
c12
lean body mass

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

OpenUrl availability

Full text

Cite this

Tetens, I. (2010). Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897. European Food Safety Authority.

Tetens, Inge. / Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 : EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897. European Food Safety Authority, 2010.

@book{060600a53d804e2e84a39d8a6d0f7798,

title = "Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897",

keywords = "anti-inflammatory cytokines, insulin sensitivity, t11 and t10, pro-inflammatory, immune defences, Conjugated linoleic acid (CLA), isomers c9, health claims, body weight, c12, lean body mass",

author = "Inge Tetens",

year = "2010",

language = "English",

publisher = "European Food Safety Authority",

}

Tetens, I 2010, Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897. European Food Safety Authority.

Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897. / Tetens, Inge.
European Food Safety Authority, 2010.

Research output: Book/Report › Report › Research › peer-review

TY - RPRT

T1 - Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

T2 - EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897

AU - Tetens, Inge

PY - 2010

Y1 - 2010

KW - anti-inflammatory cytokines

KW - insulin sensitivity

KW - t11 and t10

KW - pro-inflammatory

KW - immune defences

KW - Conjugated linoleic acid (CLA)

KW - isomers c9

KW - health claims

KW - body weight

KW - c12

KW - lean body mass

M3 - Report

BT - Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

PB - European Food Safety Authority

ER -

Tetens I. Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: EFSA-Q-2008-1285 , EFSA-Q-2008-1351 , EFSA-Q-2008-1473 , EFSA-Q-2008-1474 , EFSA-Q-2008-1513 , EFSA-Q-2008-1518 , EFSA-Q-2008-2253 , EFSA-Q-2008-2254 , EFSA-Q-2008-2255 , EFSA-Q-2008-2256 , EFSA-Q-2008-2670 , EFSA-Q-2008-3625 , EFSA-Q-2008-3897. European Food Safety Authority, 2010.